复星医药：重酒石酸去甲肾上腺素注射液药品注册申请获批

Core Viewpoint - Fosun Pharma's subsidiary, Jinzhou Aohong Pharmaceutical, has received approval from the National Medical Products Administration for the registration of a drug, norepinephrine injection, which is indicated for the treatment of acute hypotension and as an auxiliary treatment for cardiac arrest [1] Group 1 - The approved drug is indicated for restoring blood pressure in acute hypotensive states [1] - It can also be used as an auxiliary treatment for cardiac arrest and maintaining blood pressure after resuscitation [1] - The drug serves as an auxiliary treatment for shock due to hypovolemia, helping to temporarily maintain cerebral and coronary perfusion until volume resuscitation takes effect [1]